Literature DB >> 25394895

Cross-cultural measurement equivalence of the EQ-5D-5L items for English-speaking Asians in Singapore.

N Luo1, Y Wang, C H How, K Y Wong, L Shen, E G Tay, J Thumboo, M Herdman.   

Abstract

PURPOSE: To investigate how the response labels of the 5-level EQ-5D (EQ-5D-5L) items are interpreted and used by English-speaking Chinese and non-Chinese Singaporeans, as a means to assessing whether those items are cross-culturally equivalent health-status measures in this Asian population.
METHODS: In face-to-face interviews, Chinese, Malay and Indian visitors to a primary care institution in Singapore were asked to rate the relative severity conveyed by EQ-5D-5L response labels, each containing the keyword of 'no(t),' 'slight(ly),' 'moderate(ly),' 'severe(ly),' or 'unable'/'extreme(ly),' using a 0-100 numerical rating scale. Participants were also asked to describe 25 hypothetical health states using the EQ-5D-5L response labels. Differences between Chinese and Malay/Indian participants in label interpretation and selection were examined using multivariate regression analysis to adjust for participant characteristics.
RESULTS: The differences in adjusted mean severity scores for individual EQ-5D-5L labels between Chinese (n = 148) and non-Chinese (Malay: n = 53; Indian: n = 56) participants ranged from 0.0 to 9.0. The relative severity of the labels to the participants supported the ordinality of the EQ-5D-5L response labels and was similar across ethnic groups. Chinese and non-Chinese participants selected similar response labels to describe each hypothetical health state, with the adjusted odds ratios of selecting any type of the five response labels for non-Chinese versus Chinese participants ranging from 0.92 to 1.15 (p > 0.05 for all).
CONCLUSIONS: The EQ-5D-5L items are likely to generate equivalent health outcomes between English-speaking Chinese and non-Chinese Singaporeans.

Entities:  

Mesh:

Year:  2014        PMID: 25394895     DOI: 10.1007/s11136-014-0864-8

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  21 in total

Review 1.  EQ-5D: a measure of health status from the EuroQol Group.

Authors:  R Rabin; F de Charro
Journal:  Ann Med       Date:  2001-07       Impact factor: 4.709

2.  Are English- and Chinese-language versions of the SF-6D equivalent? A comparison from a population-based study.

Authors:  Hwee-Lin Wee; Yin-Bun Cheung; Kok-Yong Fong; Nan Luo; David Machin; Julian Thumboo
Journal:  Clin Ther       Date:  2004-07       Impact factor: 3.393

3.  The English and Chinese versions of the five-level EuroQoL Group's five-dimension questionnaire (EQ-5D) were valid and reliable and provided comparable scores in Asian breast cancer patients.

Authors:  Chun Fan Lee; Raymond Ng; Nan Luo; Nan Soon Wong; Yoon Sim Yap; Soo Kien Lo; Whay Kuang Chia; Alethea Yee; Lalit Krishna; Celest Wong; Cynthia Goh; Yin Bun Cheung
Journal:  Support Care Cancer       Date:  2012-06-06       Impact factor: 3.603

4.  Psychometric comparison of the standard EQ-5D to a 5 level version in cancer patients.

Authors:  A Simon Pickard; Maria C De Leon; Thomas Kohlmann; David Cella; Sarah Rosenbloom
Journal:  Med Care       Date:  2007-03       Impact factor: 2.983

5.  Tests of scaling assumptions and construct validity of the Chinese (HK) version of the SF-36 Health Survey.

Authors:  C L Lam; B Gandek; X S Ren; M S Chan
Journal:  J Clin Epidemiol       Date:  1998-11       Impact factor: 6.437

6.  Health-related quality of life and culture.

Authors:  Marjorie Kagawa-Singer; Geraldine V Padilla; Kimlin Ashing-Giwa
Journal:  Semin Oncol Nurs       Date:  2010-02       Impact factor: 2.315

7.  Minimally important difference for patient-reported outcomes in psoriatic arthritis: Health Assessment Questionnaire and pain, fatigue, and global visual analog scales.

Authors:  Tiffany Kwok; Janet E Pope
Journal:  J Rheumatol       Date:  2010-03-15       Impact factor: 4.666

8.  Clinically important differences in the intensity of chronic refractory breathlessness.

Authors:  Miriam J Johnson; J Martin Bland; Stephen G Oxberry; Amy P Abernethy; David C Currow
Journal:  J Pain Symptom Manage       Date:  2013-04-19       Impact factor: 3.612

9.  The minimally important difference for the health assessment questionnaire in rheumatoid arthritis clinical practice is smaller than in randomized controlled trials.

Authors:  Janet E Pope; Dinesh Khanna; Deborah Norrie; Janine M Ouimet
Journal:  J Rheumatol       Date:  2009-02       Impact factor: 4.666

10.  Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L).

Authors:  M Herdman; C Gudex; A Lloyd; Mf Janssen; P Kind; D Parkin; G Bonsel; X Badia
Journal:  Qual Life Res       Date:  2011-04-09       Impact factor: 4.147

View more
  5 in total

1.  Psychometric performance assessment of Malay and Malaysian English version of EQ-5D-5L in the Malaysian population.

Authors:  Asrul Akmal Shafie; Annushiah Vasan Thakumar; Ching Jou Lim; Nan Luo
Journal:  Qual Life Res       Date:  2018-10-13       Impact factor: 4.147

2.  An exploration of differences between Japan and two European countries in the self-reporting and valuation of pain and discomfort on the EQ-5D.

Authors:  Yan Feng; Mike Herdman; Floortje van Nooten; Charles Cleeland; David Parkin; Shunya Ikeda; Ataru Igarashi; Nancy J Devlin
Journal:  Qual Life Res       Date:  2017-03-25       Impact factor: 4.147

3.  Psychometric properties of the EQ-5D-5L: a systematic review of the literature.

Authors:  You-Shan Feng; Thomas Kohlmann; Mathieu F Janssen; Ines Buchholz
Journal:  Qual Life Res       Date:  2020-12-07       Impact factor: 4.147

4.  Conceptual Framework for Optimised Proxy Value Set Selection Through Supra-National Value Set Development for the EQ-5D Instruments.

Authors:  Agata Łaszewska; Ayesha Sajjad; Jan Busschbach; Judit Simon; Leona Hakkaart-van Roijen
Journal:  Pharmacoeconomics       Date:  2022-10-06       Impact factor: 4.558

5.  Feasibility and validity of the EQ-5D-3L in the elderly Europeans: a secondary data analysis using SHARE(d) data.

Authors:  Ines Buchholz; Ole Marten; Mathieu F Janssen
Journal:  Qual Life Res       Date:  2022-05-27       Impact factor: 3.440

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.